Related Experiment Videos
Triplet cervical pregnancy treated with intraamniotic methotrexate
Eun-Hwan Jeong1, Yong-Beom Kim, Ill-Woon Ji
1Department of Obstetrics and Gynecology, Chungbuk National University Hospital, Cheongju, South Korea. jeong@med.chungbuk.ac.kr
Obstetrics and Gynecology
|November 9, 2002
Summary
Multifetal cervical pregnancy, a rare condition, was successfully treated. Direct intraamniotic methotrexate injection preserved reproductive capability in a triplet pregnancy case.
Area of Science:
- Reproductive Medicine
- Maternal-Fetal Medicine
- Gynecologic Surgery
Background:
- Multifetal cervical pregnancy is an exceptionally rare obstetric complication.
- Cervical pregnancies pose significant risks, including hemorrhage and loss of reproductive potential.
- Early diagnosis and effective management are crucial for favorable outcomes.
Observation:
- A case of triplet cervical pregnancy was diagnosed in a multiparous woman via transvaginal ultrasonography.
- Embryonic cardiac activity was detected in one of the three gestational sacs within the cervix.
- The patient conceived naturally.
Findings:
- Initial treatment with a single intramuscular methotrexate dose failed.
- Successful treatment was achieved using direct intraamniotic methotrexate instillation under ultrasound guidance.
- The patient's reproductive capacity was preserved post-treatment.
Implications:
- Direct intraamniotic methotrexate instillation is a viable treatment option for multifetal cervical pregnancy.
- This approach offers a less invasive alternative, potentially improving outcomes and preserving fertility.
- Further research is warranted to establish standardized protocols for this rare condition.